ユタにおける片頭痛の臨床試験
ユタ内の拠点で、片頭痛に関する7件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04649242Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- JBR Clinical Research, Salt Lake City
- Wasatch Clinical Research , LLC(Administrative Location), Salt Lake City
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04743141A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Pantheon Clinical Research /ID# 270259, Bountiful
- Alpine Research Organization - Clinton /ID# 276527, Clinton
- Highland Clinical Research /ID# 270281, Salt Lake City
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/22更新 · NCT06810505Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Advanced Research Institute Ogden, Ogden
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/16更新 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pantheon Clinical Research /ID# 250703, Bountiful
- Highland Clinical Research /ID# 239362, Salt Lake City
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/14更新 · NCT05125302Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients
- Highland Research, Salt Lake City
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/09/02更新 · NCT07646613A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Pantheon Clinical Research, Bountiful
- J. Lewis Research, Inc. / Foothill Family Clinic Draper, Draper
- Advanced Research Institute, Ogden
- 他3件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/20更新 · NCT07645924ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。